Anteris Technologies Global Corp. AVR
5.09 USD -0.12 (-2.30%)
Regular-session close
5.20 +0.11 +2.16%
After hours · Nov 19, 6:08 PM ET
4.89 Day range 5.30
3.30 52-week range 11.06
- YTD
- +2.00%
- 1 year
- +49.71%
News
globenewswire.com Anteris Announces Late-Breaking PCR London Valves Data Release: One-Year DurAVR THV Outcomes in 100 Patients MINNEAPOLIS and BRISBANE, Australia, Nov. 16, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (“Anteris” or the “Company”) (Nasdaq: AVR; ASX: AVR) today announced that Rishi Puri, MD, PhD,…
defenseworld.net NeurAxis (NASDAQ:NRXS) and Anteris Technologies Global (NASDAQ:AVR) Head-To-Head Review NeurAxis (NASDAQ: NRXS - Get Free Report) and Anteris Technologies Global (NASDAQ: AVR - Get Free Report) are both small-cap healthcare companies, but which is the better stock? We will contrast the…benzinga.com Barclays Maintains Equal-Weight on Anteris Technologies Glb, Lowers Price Target to $9 Barclays analyst Matt Miksic maintains Anteris Technologies Glb (NASDAQ:AVR) with a Equal-Weight and lowers the price target from $10 to $9.
globenewswire.com Anteris Technologies Announces Results for the Third Quarter of 2026 MINNEAPOLIS and BRISBANE, Australia, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (“Anteris” or the “Company”) (NASDAQ: AVR, ASX: AVR), a global healthcare company committed to…
globenewswire.com Anteris Reports Medium-Size DurAVR THV Outcomes from the EMBARK Study at TCT 2026 MINNEAPOLIS and BRISBANE, Australia, Nov. 01, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (“Anteris” or the “Company”) (NASDAQ: AVR, ASX: AVR) a global healthcare company committed to…benzinga.com Anteris Technologies To Present First 30-Day Clinical And Hemodynamic Outcomes For Its Medium-Size DurAVR Transcatheter Heart Valve At The Transcatheter Cardiovascular Therapeutics Conference, October 31-November 3 The presentation will report 30-day outcomes in patients with severe aortic stenosis who received the medium-size DurAVR THV in the ongoing EMBARK study. Since 2021 over 130 patients have been…
globenewswire.com Anteris Announces Upcoming Data Release for Medium-Size DurAVR THV from EMBARK Study at TCT 2026 MINNEAPOLIS and BRISBANE, Australia, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (“Anteris” or the “Company”) (NASDAQ: AVR, ASX: AVR) today announced that Azeem Latib, MD,…
proactiveinvestors.com Anteris Technologies secures German clearance to expand PARADIGM heart valve trial Anteris Technologies Pty Ltd (ASX:AVR, NASDAQ:AVR) has secured full German regulatory clearance for its pivotal PARADIGM trial, allowing the company to begin recruiting patients in Europe's largest…
globenewswire.com Anteris Advances Global PARADIGM Trial Expansion with German Regulatory Clearance MINNEAPOLIS and BRISBANE, Australia, Oct. 19, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (“Anteris” or the “Company”) (NASDAQ: AVR, ASX: AVR) announced today that it has received full…
defenseworld.net Insider Buying: Anteris Technologies Global (NASDAQ:AVR) Major Shareholder Purchases $1,957,950.10 in Stock Anteris Technologies Global Corp. (NASDAQ: AVR - Get Free Report) major shareholder L1 Capital Pty Ltd bought 272,695 shares of the business's stock in a transaction on Tuesday, October 6th. The…
defenseworld.net Insider Buying: Anteris Technologies Global (NASDAQ:AVR) Major Shareholder Buys $1,838,834.12 in Stock Anteris Technologies Global Corp. (NASDAQ: AVR - Get Free Report) major shareholder L1 Capital Pty Ltd bought 236,354 shares of the company's stock in a transaction on Friday, October 2nd. The shares…
defenseworld.net Insider Buying: Anteris Technologies Global (NASDAQ:AVR) Major Shareholder Buys $4,869,897.05 in Stock Anteris Technologies Global Corp. (NASDAQ: AVR - Get Free Report) major shareholder L1 Capital Pty Ltd acquired 648,455 shares of the firm's stock in a transaction on Monday, October 5th. The shares…
proactiveinvestors.com Anteris Technologies appoints Brent Moen as chief financial officer Anteris Technologies Pty Ltd (ASX:AVR, NASDAQ:AVR) has appointed experienced financial executive Brent Moen as chief financial officer, effective September...
defenseworld.net BlackRock Inc. Acquires Shares of 5,771,213 Anteris Technologies Global Corp. $AVR BlackRock Inc. bought a new position in shares of Anteris Technologies Global Corp. (NASDAQ: AVR) in the second quarter, according to the company in its most recent filing with the Securities and…
globenewswire.com Anteris to Present at September Healthcare Investor Conferences MINNEAPOLIS and BRISBANE, Australia, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (“Anteris” or the “Company”) (NASDAQ: AVR, ASX: AVR) a global healthcare company committed to…
defenseworld.net ADAR1 Capital Management LLC Acquires New Position in Anteris Technologies Global Corp. $AVR ADAR1 Capital Management LLC bought a new position in shares of Anteris Technologies Global Corp. (NASDAQ: AVR) during the second quarter, according to the company in its most recent 13F filing with…
defenseworld.net Assenagon Asset Management S.A. Invests $6.35 Million in Anteris Technologies Global Corp. $AVR Assenagon Asset Management S.A. bought a new stake in Anteris Technologies Global Corp. (NASDAQ: AVR) during the undefined quarter, according to the company in its most recent disclosure with the…
globenewswire.com Anteris Technologies Announces Results for the Second Quarter of 2026 MINNEAPOLIS and BRISBANE, Australia, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (“Anteris” or the “Company”) (NASDAQ: AVR, ASX: AVR) a global healthcare company committed to…
defenseworld.net Anteris Technologies Global (NASDAQ:AVR) Major Shareholder L1 Capital Pty Ltd Sells 174,721 Shares Anteris Technologies Global Corp. (NASDAQ: AVR - Get Free Report) major shareholder L1 Capital Pty Ltd sold 174,721 shares of the company's stock in a transaction dated Thursday, August 6th. The…
proactiveinvestors.com Pennon returns to profit after water bill hikes Pennon Group PLC (LSE:PNN, OTC:PEGRY) returned to the black in its latest financial as higher regulatory allowances and increased water consumption boosted...
globenewswire.com Anteris Advances Global PARADIGM Expansion with French Regulatory Clearance MINNEAPOLIS and BRISBANE, Australia, June 08, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (“Anteris” or the “Company”) (NASDAQ: AVR, ASX: AVR) announced today that it has received full…
globenewswire.com Anteris Appoints Susan Knight and Stephen Denaro to its Board of Directors MINNEAPOLIS and BRISBANE, Australia, May 13, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (“Anteris” or the “Company”) (NASDAQ: AVR, ASX: AVR) a global structural heart company…
